U.S. flag

An official website of the United States government

GTR Home > Laboratories > GeneKor MSA

GeneKor MSA

GTR Lab ID: 505504, Last updated:2024-07-23

Personnel

  • Director: George Nasioulas, PhD, Lab Director
    Phone: +30 210 6032138
    Fax: +30 210 6032148
    Email: [email protected]
  • Konstantinos Agiannitopoulos, MSc, Molecular Biologist
    Phone: +30 210 6032138
    Fax: +30 210 6032148
    Email: [email protected]
  • Jenny Bourkoula, PhD, Group Leader of Cytogenetics
    Phone: +30 210 6032138
    Fax: +30 210 6032148
    Email: [email protected]
  • Vasiliki Metaxa-Mariatou, MSc, Molecular Biologist & QA Manager
    Phone: +30 210 6032138
    Fax: +30 210 6032148
    Email: [email protected]
  • Eirini Papadopoulou, PhD, Group Leader of Oncogenetics
    Phone: +30 210 6032138
    Fax: +30 210 603214
    Email: [email protected]
  • Georgia Pepe, MSc, Molecular Biologist
    Phone: +30 210 6032138
    Fax: +30 210 6032148
    Email: [email protected]
  • George Tsaousis, PhD, Group Leader of Bioinformatics
    Phone: +30 210 6032138
    Fax: +30 210 6032148
    Email: [email protected]

Conditions and tests

  • Acute lymphoid leukemia1 test
  • Acute myeloid leukemia1 test
  • Anaplastic large cell lymphoma1 test
  • Attenuated familial adenomatous polyposis2 tests
  • Breast adenocarcinoma1 test
  • Breast lobular carcinoma1 test
  • Breast neoplasm2 tests
  • Breast-ovarian cancer, familial, susceptibility to, 11 test
  • Breast-ovarian cancer, familial, susceptibility to, 21 test
  • Carcinoma of colon2 tests
  • Carcinoma of pancreas2 tests
  • Chronic myelogenous leukemia, BCR-ABL1 positive1 test
  • Endometrial carcinoma2 tests
  • Familial adenomatous polyposis 12 tests
  • Familial cancer of breast3 tests
  • Familial colorectal cancer4 tests
  • Familial medullary thyroid carcinoma1 test
  • Familial pancreatic carcinoma2 tests
  • Gardner syndrome2 tests
  • Gastrointestinal stromal tumor1 test
  • Glioma1 test
  • Hereditary breast ovarian cancer syndrome1 test
  • Hereditary diffuse gastric adenocarcinoma1 test
  • Lung carcinoma1 test
  • Lynch syndrome3 tests
  • Melanoma2 tests
  • Mismatch repair cancer syndrome 13 tests
  • Muir-Torré syndrome2 tests
  • Multiple endocrine neoplasia type 2A1 test
  • Multiple endocrine neoplasia type 2B1 test
  • Multiple endocrine neoplasia, type 11 test
  • Multiple endocrine neoplasia, type 21 test
  • Myelodysplastic syndrome1 test
  • Non-small cell lung carcinoma1 test
  • Ovarian cancer1 test
  • Ovarian neoplasm3 tests
  • Solid tumor1 test
  • Thyroid gland carcinoma1 test
  • Von Hippel-Lindau syndrome1 test

List of services

  • Clinical Testing/Confirmation of Mutations Identified Previously
  • Custom Sequence Analysis
  • Carrier testing
  • Genetic counseling
  • Identity Testing
  • Mutation Confirmation
  • Whole Exome Sequencing

List of certifications/licenses

Certifications

  • ISO15189, Number: 822, Expiration date: 2024-06-24
  • International Organization for Standardization 27001, Number: 048190009, Expiration date: 2022-03-03
  • International Organization for Standardization 9001, ISO9001, Number: 041150049, Expiration date: 2021-04-15

Participation in external programs

Standardization programs

  • Other

Data exchange Programs

  • Other

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.